Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor

被引:25
作者
Koriyama, Nobuyuki
Nishimoto, Kengo
Kodama, Takuro
Nakazaki, Mitsuhiro
Kurono, Yuichi
Yoshida, Hiroki
Tei, Chuwa
机构
[1] Natl Hosp Org, Kagoshima Med Ctr, Dept Diabet & Endocrine Med, Kagoshima 8920853, Japan
[2] Kagoshima Univ Hosp, Dept Diabet & Endocrine Med, Kagoshima, Japan
[3] Kagoshima Univ Hosp, Dept Otolaryngol, Kagoshima, Japan
[4] Kagoshima Univ Hosp, Dept Tumor Pathol, Kagoshima, Japan
[5] Kagoshima Univ Hosp, Dept Cardiovasc Med, Kagoshima, Japan
关键词
oncogenic; osteomalacia; mesenchymal tumor; FGF23; hypophosphatemia;
D O I
10.1097/00000441-200609000-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We herein describe the rare case of a 41-year-old woman with oncogenic osteomalacia due to a tumor in the maxillary sinus who presented with chronic general pain that had been gradually deteriorating. The patient's laboratory findings revealed hypophosphatemia due to renal phosphate wasting, an inappropriately low serum I a,25-dihydroxyvitamin D-3 level for hypophosphatemia and an unusually high serum level of fibroblast growth factor 23 (FGF23). The causative tumor was surgically removed, resulting in a rapid resolution of the patient's biochemical abnormalities. An improvement of the abnormal multiple deposits on (99)Technetium-methylene diphosphonate bone scintigraphy and an increase in the bone metabolism markers suggested the development of bone remodeling within 49 days after the operation. The pathologic diagnosis of the tumor was a "phosphaturic mesenchymal tumor, mixed with a connective tissue variant." The expression of FGF23 was demonstrated in the tumor by the immunohistochemical techniques and a Western analysis.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 28 条
  • [1] Localisation of mesenchymal tumours by somatostatin receptor imaging
    de Beur, SMJ
    Streeten, EA
    Civelek, AC
    McCarthy, EF
    Uribe, L
    Marx, SJ
    Onobrakpeya, O
    Raisz, LG
    Watts, NB
    Sharon, M
    Levine, MA
    [J]. LANCET, 2002, 359 (9308) : 761 - 763
  • [2] Tumor-Induced Osteomalacia
    Drezner M.K.
    [J]. Reviews in Endocrine and Metabolic Disorders, 2001, 2 (2) : 175 - 186
  • [3] Oncogenic osteomalacia:: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case
    Dupond, JL
    Mahammedi, H
    Prié, D
    Collin, F
    Gil, H
    Blagosklonov, O
    Ricbourg, B
    Meaux-Ruault, N
    Kantelip, B
    [J]. BONE, 2005, 36 (03) : 375 - 378
  • [4] TUMOR-INDUCED OSTEOMALACIA - UNVEILING A NEW HORMONE
    ECONS, MJ
    DREZNER, MK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) : 1679 - 1681
  • [5] Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate-wasting disorder
    Econs, MJ
    McEnery, PT
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) : 674 - 681
  • [6] Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity - An analysis of 32 cases and a comprehensive review of the literature
    Folpe, AL
    Fanburg-Smith, JC
    Billings, SD
    Bisceglia, M
    Bertoni, F
    Cho, JY
    Econs, MJ
    Inwards, CY
    de Beur, SMJ
    Mentzel, T
    Montgomery, E
    Michal, M
    Miettinen, M
    Mills, SE
    Reith, JD
    O'Connell, JX
    Rosenberg, AE
    Rubin, BP
    Sweet, DE
    Vinh, TN
    Wold, LE
    Wehrli, BM
    White, FKE
    Zaino, RJ
    Weiss, SW
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (01) : 1 - 30
  • [7] Role of fibroblast growth factor 23 in health and in chronic kidney disease
    Fukagawa, M
    Nii-Kono, T
    Kazama, JJ
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2005, 14 (04) : 325 - 329
  • [8] Oncogenic osteomalacia: case report and review of head and neck associated tumours
    Gonzalez-Compta, X
    Manos-Pujol, M
    Foglia-Fernandez, M
    Peral, E
    Condom, E
    Claveguera, T
    Dicenta-Sousa, M
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1998, 112 (04) : 389 - 392
  • [9] Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia
    Larsson, T
    Zahradnik, R
    Lavigne, J
    Ljunggren, Ö
    Jüppner, H
    Jonsson, KB
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (02) : 269 - 276
  • [10] Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
    Liu, SG
    Guo, R
    Simpson, LG
    Xiao, ZS
    Burnham, CE
    Quarles, LD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 37419 - 37426